MREO

Mereo BioPharma
MREO

Overview Fund Activity

77 hedge funds and large institutions have $435M invested in Mereo BioPharma in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 12 closing their positions.

Holders
77
Holders Change
-2
Holders Change %
-2.53%
% of All Funds
1.11%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
10
Increased
19
Reduced
24
Closed
12
Calls
$3.18M
Puts
$2.26M
Net Calls
+$929K
Net Calls Change
-$122K

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$50.9M
2
Millennium Management
2
Millennium Management
New York
$22.2M
3
Morgan Stanley
3
Morgan Stanley
New York
$9.65M
4
FLSM
4
Frazier Life Sciences Management
California
$21M
5
ACP
5
Acuta Capital Partners
California
$5.18M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$39.9M
2
IHAM
2
Integral Health Asset Management
New York
$4.11M
3
Goldman Sachs
3
Goldman Sachs
New York
$8.25M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$5.37M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1.59M
Name Market Value Shares Shares
Change 		Shares
Change %
RCMNY
1
Rubric Capital Management (New York)
New York
$62.9M 15,307,347 – –
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$50.9M 12,345,866 +4,464,984 +57%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$39.9M 9,715,013 -2,076,297 -18%
RSCM
4
Rock Springs Capital Management
Maryland
$39.2M 9,534,170 +250,678 +3%
MP
5
Mangrove Partners
Connecticut
$35.9M 8,729,720 -23,173 -0.3%
DM
6
Deerfield Management
New York
$27.6M 6,710,429 – –
Millennium Management
7
Millennium Management
New York
$22.2M 5,394,691 +2,192,986 +68%
FLSM
8
Frazier Life Sciences Management
California
$21M 5,097,779 +696,408 +16%
6CM
9
683 Capital Management
New York
$19.9M 4,849,800 -150,200 -3%
Alkeon Capital Management
10
Alkeon Capital Management
New York
$19.3M 4,698,100 – –
CC
11
Clearline Capital
New York
$13.3M 3,244,334 -82,384 -2%
TC
12
Tejara Capital
United Kingdom
$11.6M 2,829,990 +214,532 +8%
Morgan Stanley
13
Morgan Stanley
New York
$9.65M 2,347,825 +2,140,089 +1,030%
Goldman Sachs
14
Goldman Sachs
New York
$8.25M 2,008,381 -499,132 -20%
Renaissance Technologies
15
Renaissance Technologies
New York
$5.37M 1,305,371 -456,632 -26%
ACP
16
Acuta Capital Partners
California
$5.18M 1,260,700 +583,700 +86%
Marshall Wace
17
Marshall Wace
United Kingdom
$4.23M 1,028,512 -115,539 -10%
IHAM
18
Integral Health Asset Management
New York
$4.11M 1,000,000 -775,000 -44%
BOCH
19
Blue Owl Capital Holdings
New York
$3.48M 847,809 -50,000 -6%
SCM
20
Soleus Capital Management
Connecticut
$3.48M 846,953 -400,000 -32%
NIM
21
NEOS Investment Management
Connecticut
$3.43M 835,194 -124,273 -13%
PA
22
Perceptive Advisors
New York
$3.35M 815,722 -437,528 -35%
EP
23
Eversept Partners
New York
$3.2M 777,890 +281,719 +57%
AGP
24
Artia Global Partners
Florida
$1.73M 421,359 – –
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$1.59M 386,430 -453,834 -54%
1
2 3 4